 | Up a level |
Patke, Rodhan; Harris, Anna E; Woodcock, Corinne L; Thompson, Rachel; Santos, Rute; Kumari, Amber; Allegrucci, Cinzia; Archer, Nathan; Gudas, Lorraine J; Robinson, Brian D; Persson, Jenny L; Fray, Rupert; Jeyapalan, Jennie; Rutland, Catrin S; Rakha, Emad; Madhusudan, Srinivasan; Emes, Richard D; Muyangwa-Semenova, Musalwa; Alsaleem, Mansour; De Brot, Simone; ... (2024). Epitranscriptomic mechanisms of androgen signalling and prostate cancer. Neoplasia, 56, p. 101032. Elsevier 10.1016/j.neo.2024.101032
De Brot, Simone; Cobb, Jack; Alibhai, Aziza A; Jackson-Oxley, Jorja; Haque, Maria; Patke, Rodhan; Harris, Anna E; Woodcock, Corinne L; Lothion-Roy, Jennifer; Varun, Dhruvika; Thompson, Rachel; Gomes, Claudia; Kubale, Valentina; Dunning, Mark D; Jeyapalan, Jennie N; Mongan, Nigel P; Rutland, Catrin S (2024). Immunohistochemical Investigation into Protein Expression Patterns of FOXO4, IRF8 and LEF1 in Canine Osteosarcoma. Cancers, 16(10) MDPI AG 10.3390/cancers16101945
Metzler, Veronika M; De Brot, Simone; Haigh, Daisy B; Woodcock, Corinne L; Lothion-Roy, Jennifer; Harris, Anna E; Nilsson, Emeli M; Ntekim, Atara; Persson, Jenny L; Robinson, Brian D; Khani, Francesca; Laursen, Kristian B; Gudas, Lorraine J; Toss, Michael S; Madhusudan, Srinivasan; Rakha, Emad; Heery, David M; Rutland, Catrin S; Mongan, Nigel P and Jeyapalan, Jennie N (2023). The KDM5B and KDM1A lysine demethylases cooperate in regulating androgen receptor expression and signalling in prostate cancer. Frontiers in cell and developmental biology, 11, p. 1116424. Frontiers 10.3389/fcell.2023.1116424
Harris, Anna E; Metzler, Veronika M; Lothion-Roy, Jennifer; Varun, Dhruvika; Woodcock, Corinne L; Haigh, Daisy B; Endeley, Chantelle; Haque, Maria; Toss, Michael S; Alsaleem, Mansour; Persson, Jenny L; Gudas, Lorraine J; Rakha, Emad; Robinson, Brian D; Khani, Francesca; Martin, Laura M; Moyer, Jenna E; Brownlie, Juliette; Madhusudan, Srinivasan; Allegrucci, Cinzia; ... (2022). Exploring anti-androgen therapies in hormone dependent prostate cancer and new therapeutic routes for castration resistant prostate cancer. Frontiers in endocrinology, 13(1006101), p. 1006101. Frontiers Research Foundation 10.3389/fendo.2022.1006101
